| | |
PFS a
|
OS a
| |
Chemotherapy response b
|
|---|
|
Variables
|
Case No. (%)
|
HR (95% CI)
|
P Value
|
HR (95% CI)
|
P Value
|
Case No. (%)
|
OR (95% CI)
|
P Value
|
|---|
|
FIGO stage
|
|
I–II
|
18 (29.0)
|
0.552 (0.184–1.658)
|
0.290
|
0.204 (0.027–1.551)
|
0.125
|
16 (29.0)
|
-
|
-
|
|
III–IV
|
44 (71.0)
|
1
| |
1
| |
42 (71.0)
| | |
|
Let-7e expression
| | | | | | | | |
|
Low
|
23 (37.1)
|
2.037 (0.912–4.554)
|
0.083
|
3.235 (1.258–8.317)
|
0.015
|
21 (37.1)
|
19.696 (3.477–111.572)
|
0.001
|
|
High
|
39 (62.9)
|
1
| |
1
| |
37 (62.9)
|
1
| |
|
BRCA1 expression
| | | | | | | | |
|
Low
|
25 (40.3)
|
-
|
-
|
-
|
-
|
23 (40.3)
|
1
|
0.155
|
|
High
|
37 (59.7)
| | | | |
35 (59.7)
|
5.042 (0.541–47.011)
| |
|
Rad51 expression
| | | | | | | | |
|
Low
|
32 (51.6)
|
1
|
0.029
|
1
|
0.404
|
30 (51.6)
|
1
|
0.163
|
|
High
|
30 (48.4)
|
2.519 (1.098–5.779)
| |
1.500 (0.579–3.891)
| |
28 (48.4)
|
4.290 (0.553–33.26)
| |
-
EOC epithelial ovarian cancer, HR hazards ratio, CI confidence interval, PFS progression-free survival, OS overall survival, OR odds ratio, FIGO International Federation of Gynecology and Obstetrics
-
a Multivariate Cox proportional hazards Regression analysis; b Multivariate logistic regression analysis
